LICQual Level 6 Diploma in Pharmacoeconomics (D Pharmacoeconomics)

LICQual Level 6 Diploma in Pharmacoeconomics (D Pharmacoeconomics)

The LICQual Level 6 Diploma in Pharmacoeconomics (D Pharmacoeconomics) is an advanced professional qualification designed for individuals who want to understand the economic value of medicines and healthcare interventions. The purpose of this diploma is to equip you with the skills to conduct economic evaluations, interpret health data, and support evidence-based decisions in healthcare systems, pharmaceutical companies, and policy-making bodies.

One of the key benefits of this qualification is that it bridges the gap between clinical knowledge and financial decision-making. You will learn how to analyze treatment costs, measure health outcomes, and apply economic models that guide formulary choices, reimbursement decisions, and budget planning. This expertise makes you a valuable asset to any organization that needs to balance patient care with financial sustainability. By completing this diploma, you gain the confidence to contribute to strategic discussions, improve resource allocation, and ensure that healthcare investments deliver real value to patients and providers alike.

The LICQual Level 6 Diploma in Pharmacoeconomics is a stand-alone vocational qualification focused on practical, industry-relevant skills, rather than an academic degree. This makes it an ideal choice for pharmacists, healthcare managers, pharmaceutical professionals, and policy advisors who want to specialize in economic evaluation without committing to a lengthy university program. By focusing on real-world applications, cost-effectiveness analysis, and data-driven decision-making, this diploma prepares you to take on roles that shape how medicines are selected, funded, and used in modern healthcare.

Course Overview

Awarding Body

LICQual

Credits

120

Study Mood

Online

Assessment

Assignments Based

Course Study Units

  1. Introduction to Pharmacoeconomics
  2. Health Technology Assessment (HTA)
  3. Cost Analysis and Budget Impact Modelling
  4. Pharmacoeconomics Data Analysis and Research Methods
  5. Market Access and Healthcare Policy
  6. Advanced Pharmacoeconomics Project

Entry Requirements

  • Minimum age: Minimum age of 18 years
  • Educational background: Background in pharmacy, healthcare, economics, or a related field is strongly recommended
  • Language proficiency: English language proficiency is required to ensure full participation in coursework and assessments
  • Work experience: Relevant work experience in healthcare management, pharmaceutical industry, or policy development is beneficial

Who Can Enroll

This qualification is designed for healthcare and pharmaceutical professionals who want to understand the economic value of medicines and support resource-efficient decision-making.

  • Currently working in pharmacy, healthcare management, pharmaceutical industry, or health policy
  • Interested in how treatment costs, patient outcomes, and budget decisions connect
  • Looking to develop skills in economic evaluation, data interpretation, and strategic planning
  • Keen to contribute to formulary selection, reimbursement strategies, or value-based healthcare
  • Wants a specialist qualification that strengthens analytical and decision-making expertise

Course Learning Outcomes

Unit 1: Introduction to Pharmacoeconomics

By the end of this unit, learners will be able to:

  • Explain the principles and concepts of pharmacoeconomics in healthcare decision-making
  • Analyse cost-effectiveness, cost-utility, and cost-benefit frameworks
  • Evaluate the economic impact of pharmaceutical interventions on healthcare systems
  • Apply pharmacoeconomic reasoning to real-world clinical and policy scenarios

Unit 2: Health Technology Assessment (HTA)

By the end of this unit, learners will be able to:

  • Demonstrate understanding of HTA frameworks and methodologies
  • Critically assess clinical evidence, safety, and efficacy data for healthcare interventions
  • Evaluate economic and social implications of introducing new healthcare technologies
  • Apply HTA principles to inform policy, reimbursement, and resource allocation decisions

Unit 3: Cost Analysis and Budget Impact Modelling

By the end of this unit, learners will be able to:

  • Perform cost-minimisation, cost-benefit, cost-effectiveness, and cost-utility analyses
  • Develop and evaluate budget impact models for pharmaceutical interventions
  • Analyse financial implications of healthcare interventions at organisational and system levels
  • Interpret economic data to support strategic decision-making in healthcare

Unit 4: Pharmacoeconomics Data Analysis and Research Methods

By the end of this unit, learners will be able to:

  • Design pharmacoeconomic studies and select appropriate research methodologies
  • Analyse data using statistical and modelling techniques relevant to health economics
  • Critically evaluate research findings for accuracy, reliability, and applicability
  • Present pharmacoeconomic results effectively for academic, clinical, or policy audiences

Unit 5: Market Access and Healthcare Policy

By the end of this unit, learners will be able to:

  • Explain the role of pharmacoeconomics in market access and healthcare policy development
  • Analyse regulatory, pricing, and reimbursement frameworks affecting pharmaceutical products
  • Evaluate strategies for successful market access and stakeholder engagement
  • Apply pharmacoeconomic evidence to inform policy and commercial decisions

Unit 6: Advanced Pharmacoeconomics Project

By the end of this unit, learners will be able to:

  • Plan and execute an independent research project in pharmacoeconomics
  • Critically review scientific literature and economic data relevant to the project topic
  • Apply analytical and modelling skills to evaluate healthcare interventions
  • Present findings professionally, demonstrating advanced reasoning and decision-making capabilities

Frequently Asked Questions (FAQs)

This diploma prepares you for roles such as pharmacoeconomics specialist, market access analyst, health technology assessment officer, or formulary manager. It is particularly valuable for professionals working in pharmaceutical companies, government health agencies, insurance organizations, and hospital pharmacy leadership.

Yes, this qualification provides a strong foundation for advancing into senior roles such as market access director, health economics lead, or policy advisor. It demonstrates your ability to apply economic principles to real-world healthcare decisions, which is highly valued by employers. 

The LICQual Level 6 Diploma follows international vocational standards, making it relevant for learners across different healthcare systems. The principles of pharmacoeconomics—such as cost-effectiveness and resource allocation—are universally applicable, whether you work in developed or emerging markets. 

Unlike general economics courses, this diploma focuses specifically on pharmaceutical products and healthcare interventions. You learn to evaluate medicines using specialized tools like quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs).

You will learn to build economic arguments that support the inclusion or exclusion of specific medicines on hospital or national formularies. The course teaches you how to present cost-effectiveness data, budget impact analyses, and clinical outcomes in a format that decision-makers understand.

Similar Posts